Please enable browser-cookies to login and use this website. Thank you.
Agenda | Mayfield and AWS Health Innovator Summit

Overview

The AWS Loft is centrally located on Market Street and is an open venue where you can have quality conversations. This event will flow directly into AWS’s annual evening reception, which attracts hundreds of guests, and will also take place in the Loft.

From 12:00PM-1:00PM we’ll have registration and lunch. Then from 1:00PM-5:00PM, we’ll have five interactive and stimulating conversations with leading academics, policymakers, hospital system providers, and startup CEOs. See below for more information on the conversation sessions, with timing to come.

Conversation Sessions

1:00–1:55 pm
The Role of the FDA in Enabling Healthcare Innovation

Speaker: Dr. Amy P. Abernethy, M.D., Ph.D., Principal Deputy Commissioner & CIO of Food and Drug Administration (US FDA)

This session will include:

  • New initiatives at the FDA designed to power innovation
  • Recommendations on best practices for start-ups to align with regulations
  • Insights from Dr. Abernethy’s academic and entrepreneurial journey at Flatiron Health and Duke University

1:55–2:15 pm
The Largest Post-Market Study on the Drugs That Actually Work

Speaker: Atul Butte, M.D., Ph.D., Director of the Bakar Computational Health Sciences Institute, UCSF & Chief Data Scientist, University of California Health System

This session will include:

  • Key takeaways on the cost/benefit analysis of treatments from more than half a billion medication orders and prescriptions, serving 15 million patients, and 10 hospitals
  • How to derive insights from large datasets

2:15–3:30 pm
The Secrets Behind Built-to-Last Companies: Anne Wojcicki in Conversation with Four Gamechangers and Category Creators

Panelists:

  • Anne Wojcicki, Co-founder & CEO of 23andMe, in conversation with:
  • Konstantinos Alataris, Founder & former CEO of Nevro Corp., led the spine stimulator for pain management company from inception through $2B IPO
  • Stéphane Bancel, CEO of Moderna, has led the biotherapeutics company from inception to $5.8B valuation today
  • Mike Pellini, Managing Partner Section 32 & former CEO of Foundation Medicine, led the new age diagnostics company from inception through scaling (acquired by Roche in 2018 at a reported $5.3B valuation)
  • Chad Robins, Co-founder & CEO of Adaptive Biotechnologies, has led the biotools and platform company from inception to $5B valuation today

This session will include:

  • Case studies on building healthcare companies that last – mission, team, fundraising, scaling, exit
  • Leadership insights from CEO journeys

3:30–4:15 pm
Innovations in Care Delivery for Critical Conditions: The Provider POV

Panelists:

  • Sam Glick, partner in Oliver Wyman’s Health and Life Sciences Practice in conversation with leading hospital system innovators
  • Dr. Albert Chan, Chief of Digital Patient Experience, Sutter Health
  • Zak Kohane, Professor & Chair, Dept. of Biomedical Informatics, Harvard Medical School
  • Dr. Lloyd Minor, Dean, Stanford University School of Medicine
  • Dr. Lori Morgan, President & CEO, Huntington Hospital
  • Jason Springs, Co-founder & CEO, Endpoint Health

This session will include:

  • How startups can partner with hospital systems to avert fatal outcomes for critical care conditions
  • The role of technology in the ICU

4:15–5:00 pm
Evidence-Based Care, the Role of the AMA, and Reducing Barriers to Innovation

Speaker: Dr. James Madara, CEO & Executive Vice President, American Medical Association (AMA)
Moderator: Chrissy Farr, Health and Technology Reporter, CNBC.com

This session will include:

  • The role of the AMA in reducing barriers to innovation
  • How entrepreneurs can best pursue the CPT process to access providers